News

Medpace Logo

For Immediate Release: November 21, 2017

Contact
Mary Kuramoto
513-579-9911 x 12523
m.kuramoto@medpace.com

Medpace Strengthens Medical Leadership in Hematology and Oncology
Dr. Ann E. Woolfrey Joins Medpace as Senior Medical Director

CINCINNATI, OH — (November 21, 2017) – Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), announced that Ann E. Woolfrey, MD has joined Medpace as Senior Medical Director of Medical Affairs. Dr. Woolfrey is an experienced pediatric oncologist with clinical expertise in bone-marrow transplantation, blood disorders, immunology and autoimmune diseases. With the addition of Dr. Woolfrey, Medpace further strengthens its clinical development capabilities across a full range of hematologic and solid tumor indications.

About Ann E. Woolfrey, MD

Dr. Ann E. Woolfrey earned her medical degree from the University of Minnesota in Minneapolis. She completed post-doctoral training in internal medicine and pediatrics at the University of Chicago and fellowship training in pediatric hematology-oncology at the Fred Hutchinson Cancer Research Center in Seattle Washington. She is currently a Professor in the Department of Pediatrics at the University of Washington and a Full member in the Clinical Research Division at the Fred Hutchinson Cancer Research Center. She is an internationally recognized clinical researcher with more than 100 published manuscripts in referred journals.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.